Logotype for Optex Systems Holdings Inc

Optex Systems (OPXS) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Optex Systems Holdings Inc

Q3 2025 earnings summary

6 Jan, 2026

Executive summary

  • Revenue for the nine months ended June 29, 2025, increased 22.3% year-over-year to $30.0 million, driven by higher periscope production and demand in both operating segments.

  • Net income rose to $4.1 million for the nine months, up from $2.8 million in the prior year, with adjusted EBITDA up 35% to $5.7 million.

  • Gross margin for the nine months was 28.8%, nearly flat year-over-year, as higher revenue offset product mix shifts.

  • Backlog as of June 29, 2025, was $38.3 million, down 16% year-over-year, but rebounded to $45 million after new contract awards post-quarter.

  • Leadership changes included the appointment of a new President and updates to board and committee structures.

Financial highlights

  • Revenue for the quarter rose 22.6% year-over-year to $11.1 million; nine-month revenue up 22.3% to $30.0 million.

  • Net income for the quarter was $1.5 million, up from $1.3 million; nine-month net income was $4.1 million, up from $2.8 million.

  • Adjusted EBITDA for the quarter was $2.1 million, up from $1.8 million; nine-month adjusted EBITDA was $5.7 million, up from $4.2 million.

  • Operating income for the nine months increased 43.8% to $5.1 million.

  • Cash balance increased to $4.9 million at quarter-end, up from $1.0 million at prior year-end; $6 million as of the call date.

  • Working capital increased to $19.4 million from $15.1 million at prior year-end.

  • No outstanding debt as of June 29, 2025; $3 million credit line renewed.

  • Operating cash flow for nine months was $5.4 million, up from $1.0 million in the prior year period.

Outlook and guidance

  • Management expects continued positive net income and operating cash flow over the next twelve months, with plans to use cash and credit for inventory and asset acquisitions.

  • No material adverse effects anticipated from tariffs or rare earth export restrictions; future commercial product pricing will reflect any tariff impacts.

  • Backlog expected to fluctuate with timing of contract awards, not indicating a negative trend.

  • Recent contract wins and leadership changes position the company for continued growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more